Fulcrum Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Fulcrum Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts. It focuses on developing therapies for genetically defined diseases that present high unmet medical need, with an initial emphasis on rare diseases. The company pursues small-molecule approaches intended to improve patient outcomes. Fulcrum has pursued collaborations to advance its programs, including a March 2026 partnership with MedicAlert Foundation and the Sickle Cell Disease Association of America to speed access to patient-specific care plans in emergency departments for individuals living with sickle cell disease. Earlier, it announced a collaboration with Sanofi to develop and commercialize losmapimod for facioscapulohumeral muscular dystrophy.